Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL547495 | 0.91 | ALDH1A1 (0.42) | POLBALDH1A1L3MBTL1KMT2ATDP1 | |
| SCHEMBL19861151 | 0.91 | ALDH1A1 (0.42) | POLBALDH1A1L3MBTL1KMT2ATDP1 | |
| SCHEMBL4829749 | 0.84 | CA1 (0.33) | KMT2A | |
| SCHEMBL3830490 | 0.83 | ALDH1A1 (0.34) | POLBALDH1A1KMT2ASMN1; SMN2 | |
| SCHEMBL14252042 | 0.81 | ALDH1A1 (0.39) | ALDH1A1L3MBTL1KMT2ATDP1RECQL | |
| SCHEMBL14252044 | 0.81 | KMT2A (0.41) | POLBALDH1A1KMT2ATDP1SMN1; SMN2 | |
| SCHEMBL14252147 | 0.80 | ALDH1A1 (0.36) | POLBALDH1A1L3MBTL1KMT2ATDP1 | |
| SCHEMBL13821988 | 0.79 | PPM1B (0.34) | L3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL16765756 | 0.79 | ATM (0.37) | POLBALDH1A1ATMHPGD | |
| SCHEMBL20176706 | 0.76 | POLB (0.44) | POLBALDH1A1L3MBTL1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180143546-A1 | METHOD FOR PRODUCING CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-05-24 | — | — | US | disclosed |